Global and United States Corticosteroid Injections for Joint Pain Market Report & Forecast 2023-2028

Report ID: 1823393 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Corticosteroid Injections for Joint Pain Product Introduction
    1.2 Global Corticosteroid Injections for Joint Pain Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Corticosteroid Injections for Joint Pain Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Corticosteroid Injections for Joint Pain Sales in Volume for the Year 2017-2028
    1.3 United States Corticosteroid Injections for Joint Pain Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Corticosteroid Injections for Joint Pain Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Corticosteroid Injections for Joint Pain Sales in Volume for the Year 2017-2028
    1.4 Corticosteroid Injections for Joint Pain Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Corticosteroid Injections for Joint Pain in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Corticosteroid Injections for Joint Pain Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Corticosteroid Injections for Joint Pain Market Dynamics
        1.5.1 Corticosteroid Injections for Joint Pain Industry Trends
        1.5.2 Corticosteroid Injections for Joint Pain Market Drivers
        1.5.3 Corticosteroid Injections for Joint Pain Market Challenges
        1.5.4 Corticosteroid Injections for Joint Pain Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Corticosteroid Injections for Joint Pain Market Segment by Type
        2.1.1 Knee & Ankle
        2.1.2 Hip Joint
        2.1.3 Shoulder & Elbow
        2.1.4 Facet Joints of the Spine
        2.1.5 Others
    2.2 Global Corticosteroid Injections for Joint Pain Market Size by Type
        2.2.1 Global Corticosteroid Injections for Joint Pain Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Corticosteroid Injections for Joint Pain Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Corticosteroid Injections for Joint Pain Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Corticosteroid Injections for Joint Pain Market Size by Type
        2.3.1 United States Corticosteroid Injections for Joint Pain Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Corticosteroid Injections for Joint Pain Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Corticosteroid Injections for Joint Pain Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Corticosteroid Injections for Joint Pain Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Retail Pharmacies
        3.1.3 Online Pharmacies
    3.2 Global Corticosteroid Injections for Joint Pain Market Size by Application
        3.2.1 Global Corticosteroid Injections for Joint Pain Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Corticosteroid Injections for Joint Pain Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Corticosteroid Injections for Joint Pain Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Corticosteroid Injections for Joint Pain Market Size by Application
        3.3.1 United States Corticosteroid Injections for Joint Pain Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Corticosteroid Injections for Joint Pain Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Corticosteroid Injections for Joint Pain Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Corticosteroid Injections for Joint Pain Competitor Landscape by Company
    4.1 Global Corticosteroid Injections for Joint Pain Market Size by Company
        4.1.1 Top Global Corticosteroid Injections for Joint Pain Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Corticosteroid Injections for Joint Pain Revenue by Manufacturer (2017-2022)
        4.1.3 Global Corticosteroid Injections for Joint Pain Sales by Manufacturer (2017-2022)
        4.1.4 Global Corticosteroid Injections for Joint Pain Price by Manufacturer (2017-2022)
    4.2 Global Corticosteroid Injections for Joint Pain Concentration Ratio (CR)
        4.2.1 Corticosteroid Injections for Joint Pain Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Corticosteroid Injections for Joint Pain in 2021
        4.2.3 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Corticosteroid Injections for Joint Pain Manufacturing Base Distribution, Product Type
        4.3.1 Global Corticosteroid Injections for Joint Pain Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Corticosteroid Injections for Joint Pain Product Type
        4.3.3 Date of International Manufacturers Enter into Corticosteroid Injections for Joint Pain Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Corticosteroid Injections for Joint Pain Market Size by Company
        4.5.1 Top Corticosteroid Injections for Joint Pain Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Corticosteroid Injections for Joint Pain Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Corticosteroid Injections for Joint Pain Sales by Players (2020, 2021 & 2022)
5 Global Corticosteroid Injections for Joint Pain Market Size by Region
    5.1 Global Corticosteroid Injections for Joint Pain Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Corticosteroid Injections for Joint Pain Market Size in Volume by Region (2017-2028)
        5.2.1 Global Corticosteroid Injections for Joint Pain Sales in Volume by Region: 2017-2022
        5.2.2 Global Corticosteroid Injections for Joint Pain Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Corticosteroid Injections for Joint Pain Market Size in Value by Region (2017-2028)
        5.3.1 Global Corticosteroid Injections for Joint Pain Sales in Value by Region: 2017-2022
        5.3.2 Global Corticosteroid Injections for Joint Pain Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Corticosteroid Injections for Joint Pain Market Size YoY Growth 2017-2028
        6.1.2 North America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Corticosteroid Injections for Joint Pain Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Corticosteroid Injections for Joint Pain Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Corticosteroid Injections for Joint Pain Market Size YoY Growth 2017-2028
        6.3.2 Europe Corticosteroid Injections for Joint Pain Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Corticosteroid Injections for Joint Pain Market Size YoY Growth 2017-2028
        6.4.2 Latin America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Corticosteroid Injections for Joint Pain Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Allergan
        7.1.1 Allergan Corporation Information
        7.1.2 Allergan Description and Business Overview
        7.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Allergan Corticosteroid Injections for Joint Pain Products Offered
        7.1.5 Allergan Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Corporation Information
        7.2.2 Pfizer Description and Business Overview
        7.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Pfizer Corticosteroid Injections for Joint Pain Products Offered
        7.2.5 Pfizer Recent Development
    7.3 Sanofi
        7.3.1 Sanofi Corporation Information
        7.3.2 Sanofi Description and Business Overview
        7.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Sanofi Corticosteroid Injections for Joint Pain Products Offered
        7.3.5 Sanofi Recent Development
    7.4 Anika Therapeutics
        7.4.1 Anika Therapeutics Corporation Information
        7.4.2 Anika Therapeutics Description and Business Overview
        7.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Products Offered
        7.4.5 Anika Therapeutics Recent Development
    7.5 Ferring
        7.5.1 Ferring Corporation Information
        7.5.2 Ferring Description and Business Overview
        7.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Ferring Corticosteroid Injections for Joint Pain Products Offered
        7.5.5 Ferring Recent Development
    7.6 Bioventus
        7.6.1 Bioventus Corporation Information
        7.6.2 Bioventus Description and Business Overview
        7.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Bioventus Corticosteroid Injections for Joint Pain Products Offered
        7.6.5 Bioventus Recent Development
    7.7 Flexion Therapeutics
        7.7.1 Flexion Therapeutics Corporation Information
        7.7.2 Flexion Therapeutics Description and Business Overview
        7.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Products Offered
        7.7.5 Flexion Therapeutics Recent Development
    7.8 Zimmer Biomet
        7.8.1 Zimmer Biomet Corporation Information
        7.8.2 Zimmer Biomet Description and Business Overview
        7.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Products Offered
        7.8.5 Zimmer Biomet Recent Development
    7.9 SEIKAGAKU
        7.9.1 SEIKAGAKU Corporation Information
        7.9.2 SEIKAGAKU Description and Business Overview
        7.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Products Offered
        7.9.5 SEIKAGAKU Recent Development
    7.10 Chugai Pharma
        7.10.1 Chugai Pharma Corporation Information
        7.10.2 Chugai Pharma Description and Business Overview
        7.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Products Offered
        7.10.5 Chugai Pharma Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Corticosteroid Injections for Joint Pain Industry Chain Analysis
    8.2 Corticosteroid Injections for Joint Pain Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Corticosteroid Injections for Joint Pain Distributors
    8.3 Corticosteroid Injections for Joint Pain Production Mode & Process
    8.4 Corticosteroid Injections for Joint Pain Sales and Marketing
        8.4.1 Corticosteroid Injections for Joint Pain Sales Channels
        8.4.2 Corticosteroid Injections for Joint Pain Distributors
    8.5 Corticosteroid Injections for Joint Pain Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Corticosteroid Injections for Joint Pain CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Corticosteroid Injections for Joint Pain Market Trends
    Table 3. Corticosteroid Injections for Joint Pain Market Drivers
    Table 4. Corticosteroid Injections for Joint Pain Market Challenges
    Table 5. Corticosteroid Injections for Joint Pain Market Restraints
    Table 6. Global Corticosteroid Injections for Joint Pain Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Corticosteroid Injections for Joint Pain Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Corticosteroid Injections for Joint Pain Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Corticosteroid Injections for Joint Pain Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Corticosteroid Injections for Joint Pain Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Corticosteroid Injections for Joint Pain Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Corticosteroid Injections for Joint Pain Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Corticosteroid Injections for Joint Pain Sales Share by Manufacturer, 2017-2022
    Table 15. Global Corticosteroid Injections for Joint Pain Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Corticosteroid Injections for Joint Pain Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Corticosteroid Injections for Joint Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroid Injections for Joint Pain as of 2021)
    Table 18. Top Players of Corticosteroid Injections for Joint Pain in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Corticosteroid Injections for Joint Pain Product Type
    Table 20. Date of International Manufacturers Enter into Corticosteroid Injections for Joint Pain Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Corticosteroid Injections for Joint Pain Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Corticosteroid Injections for Joint Pain Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Corticosteroid Injections for Joint Pain Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Corticosteroid Injections for Joint Pain Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Corticosteroid Injections for Joint Pain Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Corticosteroid Injections for Joint Pain Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Corticosteroid Injections for Joint Pain Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Corticosteroid Injections for Joint Pain Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Corticosteroid Injections for Joint Pain Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Corticosteroid Injections for Joint Pain Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Corticosteroid Injections for Joint Pain Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Corticosteroid Injections for Joint Pain Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Corticosteroid Injections for Joint Pain Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Corticosteroid Injections for Joint Pain Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Corticosteroid Injections for Joint Pain Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Corticosteroid Injections for Joint Pain Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Corticosteroid Injections for Joint Pain Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Corticosteroid Injections for Joint Pain Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Corticosteroid Injections for Joint Pain Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Corticosteroid Injections for Joint Pain Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Allergan Corporation Information
    Table 43. Allergan Description and Business Overview
    Table 44. Allergan Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Allergan Corticosteroid Injections for Joint Pain Product
    Table 46. Allergan Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Sanofi Corporation Information
    Table 53. Sanofi Description and Business Overview
    Table 54. Sanofi Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Sanofi Product
    Table 56. Sanofi Recent Development
    Table 57. Anika Therapeutics Corporation Information
    Table 58. Anika Therapeutics Description and Business Overview
    Table 59. Anika Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Anika Therapeutics Product
    Table 61. Anika Therapeutics Recent Development
    Table 62. Ferring Corporation Information
    Table 63. Ferring Description and Business Overview
    Table 64. Ferring Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Ferring Product
    Table 66. Ferring Recent Development
    Table 67. Bioventus Corporation Information
    Table 68. Bioventus Description and Business Overview
    Table 69. Bioventus Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Bioventus Product
    Table 71. Bioventus Recent Development
    Table 72. Flexion Therapeutics Corporation Information
    Table 73. Flexion Therapeutics Description and Business Overview
    Table 74. Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Flexion Therapeutics Product
    Table 76. Flexion Therapeutics Recent Development
    Table 77. Zimmer Biomet Corporation Information
    Table 78. Zimmer Biomet Description and Business Overview
    Table 79. Zimmer Biomet Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Zimmer Biomet Product
    Table 81. Zimmer Biomet Recent Development
    Table 82. SEIKAGAKU Corporation Information
    Table 83. SEIKAGAKU Description and Business Overview
    Table 84. SEIKAGAKU Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. SEIKAGAKU Product
    Table 86. SEIKAGAKU Recent Development
    Table 87. Chugai Pharma Corporation Information
    Table 88. Chugai Pharma Description and Business Overview
    Table 89. Chugai Pharma Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Chugai Pharma Product
    Table 91. Chugai Pharma Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Corticosteroid Injections for Joint Pain Customers List
    Table 95. Corticosteroid Injections for Joint Pain Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Corticosteroid Injections for Joint Pain Product Picture
    Figure 2. Global Corticosteroid Injections for Joint Pain Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Corticosteroid Injections for Joint Pain Market Size 2017-2028 (US$ Million)
    Figure 4. Global Corticosteroid Injections for Joint Pain Sales 2017-2028 (K Units)
    Figure 5. United States Corticosteroid Injections for Joint Pain Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Corticosteroid Injections for Joint Pain Market Size 2017-2028 (US$ Million)
    Figure 7. United States Corticosteroid Injections for Joint Pain Sales 2017-2028 (K Units)
    Figure 8. United States Corticosteroid Injections for Joint Pain Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Corticosteroid Injections for Joint Pain Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Corticosteroid Injections for Joint Pain Report Years Considered
    Figure 11. Product Picture of Knee & Ankle
    Figure 12. Product Picture of Hip Joint
    Figure 13. Product Picture of Shoulder & Elbow
    Figure 14. Product Picture of Facet Joints of the Spine
    Figure 15. Product Picture of Others
    Figure 16. Global Corticosteroid Injections for Joint Pain Market Share by Type in 2022 & 2028
    Figure 17. Global Corticosteroid Injections for Joint Pain Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Corticosteroid Injections for Joint Pain Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Corticosteroid Injections for Joint Pain Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Corticosteroid Injections for Joint Pain Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Corticosteroid Injections for Joint Pain Price by Type (2017-2028) & (USD/Unit)
    Figure 22. United States Corticosteroid Injections for Joint Pain Market Share by Type in 2022 & 2028
    Figure 23. United States Corticosteroid Injections for Joint Pain Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Corticosteroid Injections for Joint Pain Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Corticosteroid Injections for Joint Pain Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Corticosteroid Injections for Joint Pain Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Corticosteroid Injections for Joint Pain Price by Type (2017-2028) & (USD/Unit)
    Figure 28. Product Picture of Hospital Pharmacies
    Figure 29. Product Picture of Retail Pharmacies
    Figure 30. Product Picture of Online Pharmacies
    Figure 31. Global Corticosteroid Injections for Joint Pain Market Share by Application in 2022 & 2028
    Figure 32. Global Corticosteroid Injections for Joint Pain Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Corticosteroid Injections for Joint Pain Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Corticosteroid Injections for Joint Pain Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Corticosteroid Injections for Joint Pain Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Corticosteroid Injections for Joint Pain Price by Application (2017-2028) & (USD/Unit)
    Figure 37. United States Corticosteroid Injections for Joint Pain Market Share by Application in 2022 & 2028
    Figure 38. United States Corticosteroid Injections for Joint Pain Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Corticosteroid Injections for Joint Pain Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Corticosteroid Injections for Joint Pain Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Corticosteroid Injections for Joint Pain Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Corticosteroid Injections for Joint Pain Price by Application (2017-2028) & (USD/Unit)
    Figure 43. North America Corticosteroid Injections for Joint Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Corticosteroid Injections for Joint Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Corticosteroid Injections for Joint Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Corticosteroid Injections for Joint Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Corticosteroid Injections for Joint Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Corticosteroid Injections for Joint Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Corticosteroid Injections for Joint Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Corticosteroid Injections for Joint Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Corticosteroid Injections for Joint Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Corticosteroid Injections for Joint Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Corticosteroid Injections for Joint Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Corticosteroid Injections for Joint Pain Value Chain
    Figure 77. Corticosteroid Injections for Joint Pain Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet
SEIKAGAKU
Chugai Pharma
Frequently Asked Questions
Corticosteroid Injections for Joint Pain report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Corticosteroid Injections for Joint Pain report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Corticosteroid Injections for Joint Pain report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports